Sarah Okonkwo
270 stories · Page 11 of 12
The textbook said B cells take turns. A new temporal map of a malaria infection says they don't.
A new Nature Immunology temporal map of B cell responses to malaria in mice catches class-switching, clonal expansion, and somatic hypermutation overlapping from the first week, scrambling the tidy stepwise story textbooks still teach.
Nutrition & FoodThe bitter finish in your protein shake isn't the protein. It's the minerals.
A new sensory study traces the bitter, peppery aftertaste in whey protein shakes to minerals that get concentrated during filtration, not the protein itself. The fix is a manufacturing tweak. The co-author is the supplier that sells the alpha-lactalbumin line.
Nutrition & FoodThe sugar-free mice got sicker, and the press release left out what they were eating instead
A 16-week mouse study presented at ENDO 2026 reported that sugar-free animals developed insulin resistance, gut dysbiosis and fatty liver at the same body weight as controls. The press release never says what replaced the sugar, and that single missing detail decides what the study actually means.
Brain & AgingMiddle-aged Americans Are Weaker, Lonelier, and Forgetting More Than Their Parents Did at the Same Age
A 17-country study finds U.S. adults in their 50s are doing worse on memory, grip strength, loneliness, and depression than their parents were. The United States is the only country going meaningfully backward.
Autoimmune & InflammationYour Thymus Quietly Stages a Lung. Researchers Just Named the Cell Playing the Part.
A new Nature Immunology study identifies an alveolar lung-like cell hiding inside the thymus, where it appears to teach the immune system not to attack your real lungs.
Brain & AgingBrain Gains Into Your 90s Are Probably Real. The Index Measuring Them Has a Patent Pending.
A three-year UT Dallas study tracking nearly 4,000 adults to age 94 says brain function can climb at any age. The biology is plausible. The catch is that the people measuring the gain are the same people patenting the yardstick.
Brain & AgingThe Same Mutations That Drive Blood Cancer Keep Turning Up in Alzheimer's Brains
A new Cell paper finds Alzheimer's brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.
Drugs & FDAMedicare's Product-Hopping Loophole Is Back On The Chopping Block. The Bigger Pharma Giveaway Isn't.
The Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare's negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.
Autoimmune & InflammationA near-starvation diet shifted inflammation in gum-disease patients. The trial was tiny, and the diet came in a box.
A 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren't reported. The biology question is real; the data is thin.
Brain & AgingNitrate from spinach behaves nothing like nitrate from tap water. A 27-year cohort says the brain can tell.
54,804 Danes followed for a quarter-century: less dementia from vegetable nitrate, more from drinking water. The risk signal shows up at roughly one-ninth of what the US EPA still permits.
Drugs & FDAEurope had this sunscreen in 1999. The FDA approved it Tuesday.
A new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency's own 2019 review could not call safe.
Brain & AgingDisappointment, Not Reward, Is What Breaks a Habit. Half of Older Adults Are on Drugs That Blunt Acetylcholine.
An OIST team caught the mouse brain firing acetylcholine the moment an expected reward failed to land. That surge is what lets the animal switch strategy. Close to half of community-dwelling older adults are on drugs that block the same receptors.
Nutrition & FoodAmerican Doctors Get About 1.2 Hours of Nutrition Training a Year. RFK Jr. Just Found the Lever.
Kennedy got eight organizations across U.S. medical training and 73 medical schools to commit to nutrition in licensing, accreditation, and a 40-hour pledge. The board exam matters; the rest is partly hedging.
Nutrition & Food8,300 Brazilian elders, one saltshaker, and the 80 percent of sodium nobody mentions
A Frontiers in Public Health survey of 8,336 Brazilians over 60 found older men reach for the saltshaker most. Buried in the same paper: the shaker only accounts for 6 to 20 percent of total sodium. The other 70-plus percent already arrived from the factory.
Brain & AgingThe Alzheimer's Drug That Bets the Plaques Are a Symptom
An ETH Zurich team spent nearly twenty years tracing why Alzheimer's nerve cells run out of energy, and the answer points to a protein the amyloid-clearing drugs never touched.
Autoimmune & InflammationFish oil rewired the T-cells in non-obese diabetic rats, and the glucose moved with them
A Brazilian team gave EPA-heavy fish oil to a non-obese diabetic rat strain for eight weeks. Glucose, insulin sensitivity, and lipids all moved in the friendlier direction. The T-cell balance shifted alongside them, and that is the part of the paper worth chewing on.
Metabolic & WeightThe Oral GLP-1 Race Just Got a Third Serious Contender, and Its Curve Was Still Climbing
Structure Therapeutics' once-daily oral GLP-1 aleniglipron hit 11.3 percent placebo-adjusted weight loss at 36 weeks and kept climbing in the open label. The catch: oral semaglutide and orforglipron already cleared the FDA.
InvestigationsThe Hernia FAQ That Forgets to Mention the Implant
A polished hernia FAQ walks patients through recovery time, return-to-work, and lifestyle. It skips the question with 26,153 pending lawsuits behind it, and the no-mesh option the international guideline still keeps on the table.
Autoimmune & InflammationThe Herbal Steroid That Hits Pharma's Holy-Grail Kidney Target
A Shanghai lab reports a steroid from a Yunnan mountain plant, already sold over the counter to bodybuilders, suppresses the same kidney-fibrosis pathway Big Pharma keeps circling and never quite closes on.
Metabolic & WeightRetatrutide's Triple-Receptor Triumph Came With a One-in-Five Skin-Sensation Signal Nobody Wanted to Linger On
Eli Lilly's investigational retatrutide hit bariatric-surgery-level weight loss at ADA 2026. The highest-dose arm of TRIUMPH-4 also saw 20.9% of patients report abnormal skin sensations, and a small cardiac imbalance turned up in the type-2 trial. Both got far less stage time than the headline numbe
Metabolic & WeightLilly's triple agonist hit 30% weight loss. The glucagon bet is why.
Lilly's triple agonist hit nearly 30% weight loss at 104 weeks at ADA 2026. The glucagon bet is what makes retatrutide different from semaglutide and Mounjaro, and it's what makes the open safety signals different too.
Nutrition & FoodHe Shou Wu's Hair-Loss Pitch Is Better Than I Expected. Its Liver Record Is Worse.
Researchers at Guangdong Pharmaceutical University argue Polygonum multiflorum could become the next pattern-baldness lead. The follicle biology is interesting. The case series of acute liver failure on four continents are not.
InvestigationsA 16-Foot Fire Tornado Burned an Oil Slick With 40% Less Soot. Cleanup Crews Have Been Breathing the Same Old Smoke Since the Exxon Valdez.
A federally funded field trial used a controlled fire whirl to burn up to 95% of a crude oil pool while cutting soot by 40%, raising the question of why the standard in-situ burn, with its measured worker-lung cost, has gone unchallenged for thirty-five years.
InvestigationsCops shoved a doctor at the ADA meeting. The editorial they tore up has its own credibility problem.
Police escorted ADA members out of New Orleans on Friday for passing out an editorial against Trump's NIH overhaul. The shove was bad. The editorial defending the status quo has a credibility problem the press is mostly missing.